Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monoteraphy in patients with chronic hepatitis B. A multicenter, randomized trial

2001 ◽  
Vol 34 ◽  
pp. 136
Author(s):  
G. Barbaro ◽  
F. Zechini ◽  
A.M. Pellicelli ◽  
R. Francavilla ◽  
G. Scotto ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Randomized Trial ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Multicenter Randomized Trial ◽  
Term Efficacy ◽  
Interferon Alpha 2B

Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B

2009 ◽  
Vol 46 (2) ◽  
pp. 117-123 ◽  
Author(s):  
Pisit Tangkijvanich ◽  
Piyawat Komolmit ◽  
Varocha Mahachai ◽  
Pattaratida Sa-nguanmoo ◽  
Apiradee Theamboonlers ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Hbsag Level ◽  
Interferon Alpha 2B ◽  
Serum Hbsag ◽  
Predictors Of Response ◽  
Serum Hbsag Level ◽  
Pretreatment Serum

Long-Term Results of Interferon Alpha Monotherapy in Patients with HBeAg-Negative Chronic Hepatitis B

2007 ◽  
Vol 52 (3) ◽  
pp. 727-731 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Ahmet Danalioglu ◽  
Kadir Demir ◽  
Cetin Karaca ◽  
Filiz Akyuz ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Long Term Results ◽  
Negative Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document